FENC insider transactions
Fennec Pharmaceuticals Inc. (FENC) Form 4 insider transactions - real-time wire coverage of every officer, director, and 10% owner trade.
Recent Form 3, 4, and 5 filings for FENC
- SEC Form 4 filed by Director Brughera Marco Maria4 - FENNEC PHARMACEUTICALS INC. (0001211583) (Issuer)
- SEC Form 4 filed by Director Cook Jodi A4 - FENNEC PHARMACEUTICALS INC. (0001211583) (Issuer)
- SEC Form 4 filed by Director Islam Khalid4 - FENNEC PHARMACEUTICALS INC. (0001211583) (Issuer)
- SEC Form 4 filed by Director Rallis Chris A4 - FENNEC PHARMACEUTICALS INC. (0001211583) (Issuer)
- Director Raykov Rosty was granted 2,778 shares, exercised 15,597 shares at a strike of $2.45 and sold $93,766 worth of shares (9,747 units at $9.62) as part of a pre-agreed trading plan, increasing direct ownership by 7% to 130,079 units (SEC Form 4)4 - FENNEC PHARMACEUTICALS INC. (0001211583) (Issuer)
- Chief Strategy Officer Cioffi Christiana Marie was granted 156 shares, increasing direct ownership by 0.65% to 24,176 units (SEC Form 4)4 - FENNEC PHARMACEUTICALS INC. (0001211583) (Issuer)
- Chief Executive Officer Hackman Jeffrey S. was granted 1,159 shares, increasing direct ownership by 2% to 62,825 units (SEC Form 4)4 - FENNEC PHARMACEUTICALS INC. (0001211583) (Issuer)
- CHIEF FINANCIAL OFFICER Andrade Robert was granted 1,703 shares, increasing direct ownership by 0.59% to 289,269 units (SEC Form 4)4 - FENNEC PHARMACEUTICALS INC. (0001211583) (Issuer)
- Chief Medical Officer Sayad Pierre Sargis was granted 168 shares, increasing direct ownership by 0.81% to 21,015 units (SEC Form 4)4 - FENNEC PHARMACEUTICALS INC. (0001211583) (Issuer)
- Chief Commercial Officer Evans Terry L was granted 168 shares, increasing direct ownership by 0.81% to 21,015 units (SEC Form 4)4 - FENNEC PHARMACEUTICALS INC. (0001211583) (Issuer)
- Director Rallis Chris A exercised 14,344 shares at a strike of $2.44 and sold $58,756 worth of shares (8,346 units at $7.04) as part of a pre-agreed trading plan, increasing direct ownership by 11% to 63,077 units (SEC Form 4)4 - FENNEC PHARMACEUTICALS INC. (0001211583) (Issuer)
- Director Raykov Rosty exercised 18,376 shares at a strike of $2.08 and sold $69,753 worth of shares (10,781 units at $6.47) as part of a pre-agreed trading plan, increasing direct ownership by 7% to 121,451 units (SEC Form 4)4 - FENNEC PHARMACEUTICALS INC. (0001211583) (Issuer)
- Chief Strategy Officer Cioffi Christiana Marie converted options into 155 shares, increasing direct ownership by 0.65% to 24,020 units (SEC Form 4)4 - FENNEC PHARMACEUTICALS INC. (0001211583) (Issuer)
- Chief Commercial Officer Evans Terry L converted options into 168 shares, increasing direct ownership by 0.81% to 20,847 units (SEC Form 4)4 - FENNEC PHARMACEUTICALS INC. (0001211583) (Issuer)
- Chief Medical Officer Sayad Pierre Sargis converted options into 168 shares, increasing direct ownership by 0.81% to 20,847 units (SEC Form 4)4 - FENNEC PHARMACEUTICALS INC. (0001211583) (Issuer)
- Chief Executive Officer Hackman Jeffrey S. converted options into 1,159 shares, increasing direct ownership by 2% to 61,666 units (SEC Form 4)4 - FENNEC PHARMACEUTICALS INC. (0001211583) (Issuer)
- CHIEF FINANCIAL OFFICER Andrade Robert converted options into 1,703 shares, increasing direct ownership by 0.60% to 287,566 units (SEC Form 4)4 - FENNEC PHARMACEUTICALS INC. (0001211583) (Issuer)
- SEC Form 4 filed by Cioffi Christiana Marie4 - FENNEC PHARMACEUTICALS INC. (0001211583) (Issuer)
- SEC Form 4 filed by Hackman Jeffrey S.4 - FENNEC PHARMACEUTICALS INC. (0001211583) (Issuer)
- SEC Form 4 filed by Raykov Rosty4 - FENNEC PHARMACEUTICALS INC. (0001211583) (Issuer)
- SEC Form 4 filed by Sayad Pierre Sargis4 - FENNEC PHARMACEUTICALS INC. (0001211583) (Issuer)
- SEC Form 4 filed by Evans Terry L4 - FENNEC PHARMACEUTICALS INC. (0001211583) (Issuer)
- SEC Form 4 filed by Andrade Robert4 - FENNEC PHARMACEUTICALS INC. (0001211583) (Issuer)
- SEC Form 4 filed by Andrade Robert4 - FENNEC PHARMACEUTICALS INC. (0001211583) (Issuer)
- SEC Form 4 filed by Cioffi Christiana Marie4 - FENNEC PHARMACEUTICALS INC. (0001211583) (Issuer)
- CHIEF FINANCIAL OFFICER Andrade Robert was granted 1,191 shares, increasing direct ownership by 0.49% to 243,584 units (SEC Form 4)4 - FENNEC PHARMACEUTICALS INC. (0001211583) (Issuer)
- Director Raykov Rosty exercised 15,598 shares at a strike of $2.45, sold $84,260 worth of shares (10,079 units at $8.36) and was granted 5,208 shares, increasing direct ownership by 11% to 109,204 units (SEC Form 4)4 - FENNEC PHARMACEUTICALS INC. (0001211583) (Issuer)
- Chief Executive Officer Hackman Jeffrey S. converted options into 13,710 shares, increasing direct ownership by 91% to 28,710 units (SEC Form 4)4 - FENNEC PHARMACEUTICALS INC. (0001211583) (Issuer)
- CHIEF FINANCIAL OFFICER Andrade Robert exercised 29,735 shares at a strike of $0.34, increasing direct ownership by 14% to 242,393 units (SEC Form 4)4 - FENNEC PHARMACEUTICALS INC. (0001211583) (Issuer)
- Director Raykov Rosty exercised 15,598 shares at a strike of $2.45 and sold $80,308 worth of shares (10,349 units at $7.76), increasing direct ownership by 6% to 98,477 units (SEC Form 4)4 - FENNEC PHARMACEUTICALS INC. (0001211583) (Issuer)
- Director Raykov Rosty was granted 5,208 shares, increasing direct ownership by 6% to 93,228 units (SEC Form 4)4 - FENNEC PHARMACEUTICALS INC. (0001211583) (Issuer)
- CHIEF FINANCIAL OFFICER Andrade Robert was granted 1,558 shares, increasing direct ownership by 0.74% to 212,658 units (SEC Form 4)4 - FENNEC PHARMACEUTICALS INC. (0001211583) (Issuer)
- CHIEF FINANCIAL OFFICER Andrade Robert exercised 10,000 shares at a strike of $2.45, increasing direct ownership by 5% to 211,100 units (SEC Form 4)4 - FENNEC PHARMACEUTICALS INC. (0001211583) (Issuer)
- CHIEF FINANCIAL OFFICER Andrade Robert exercised 10,000 shares at a strike of $2.45, increasing direct ownership by 5% to 201,100 units (SEC Form 4)4 - FENNEC PHARMACEUTICALS INC. (0001211583) (Issuer)
- CHIEF FINANCIAL OFFICER Andrade Robert exercised 14,184 shares at a strike of $2.45, increasing direct ownership by 8% to 191,100 units (SEC Form 4)4 - FENNEC PHARMACEUTICALS INC. (0001211583) (Issuer)
- CHIEF FINANCIAL OFFICER Andrade Robert was granted 1,382 shares, increasing direct ownership by 0.79% to 176,916 units (SEC Form 4)4 - FENNEC PHARMACEUTICALS INC. (0001211583) (Issuer)
- Director Raykov Rosty exercised 15,598 shares at a strike of $2.45, sold $78,371 worth of shares (10,312 units at $7.60) and was granted 5,208 shares, increasing direct ownership by 14% to 88,020 units (SEC Form 4)4 - FENNEC PHARMACEUTICALS INC. (0001211583) (Issuer)
- Large owner Southpoint Capital Advisors Lp sold $7,500,000 worth of shares (1,000,000 units at $7.50) (SEC Form 4)4 - FENNEC PHARMACEUTICALS INC. (0001211583) (Issuer)
- Director Raykov Rosty sold $75,400 worth of shares (10,000 units at $7.54), decreasing direct ownership by 11% to 77,526 units (SEC Form 4)4 - FENNEC PHARMACEUTICALS INC. (0001211583) (Issuer)
- SEC Form 4 filed by Fennec Pharmaceuticals Inc.4 - FENNEC PHARMACEUTICALS INC. (0001211583) (Issuer)
- Director Raykov Rosty was granted 5,208 shares, increasing direct ownership by 6% to 87,526 units (SEC Form 4)4 - FENNEC PHARMACEUTICALS INC. (0001211583) (Issuer)
- Large owner Southpoint Capital Advisors Lp sold $170,048 worth of shares (19,341 units at $8.79) (SEC Form 4)4 - FENNEC PHARMACEUTICALS INC. (0001211583) (Issuer)
- Large owner Southpoint Capital Advisors Lp sold $2,035,625 worth of shares (246,018 units at $8.27) (SEC Form 4)4 - FENNEC PHARMACEUTICALS INC. (0001211583) (Issuer)
- Director Raykov Rosty sold $81,000 worth of shares (10,000 units at $8.10), decreasing direct ownership by 11% to 82,318 units (SEC Form 4)4 - FENNEC PHARMACEUTICALS INC. (0001211583) (Issuer)
- Director Raykov Rosty was granted 5,208 shares, increasing direct ownership by 6% to 92,318 units (SEC Form 4)4 - FENNEC PHARMACEUTICALS INC. (0001211583) (Issuer)
- CHIEF FINANCIAL OFFICER Andrade Robert was granted 2,430 shares, increasing direct ownership by 1% to 173,104 units (SEC Form 4)4 - FENNEC PHARMACEUTICALS INC. (0001211583) (Issuer)
- Director Rallis Chris A exercised 4,062 shares at a strike of $1.23 and sold $16,401 worth of shares (1,775 units at $9.24), increasing direct ownership by 4% to 57,079 units (SEC Form 4)4 - FENNEC PHARMACEUTICALS INC. (0001211583) (Issuer)
- Large owner Southpoint Capital Advisors Lp sold $636,229 worth of shares (67,114 units at $9.48) (SEC Form 4)4 - FENNEC PHARMACEUTICALS INC. (0001211583) (Issuer)
- Director Raykov Rosty exercised 4,609 shares at a strike of $2.45, increasing direct ownership by 6% to 87,110 units (SEC Form 4)4 - FENNEC PHARMACEUTICALS INC. (0001211583) (Issuer)
- Director Raykov Rosty sold $97,800 worth of shares (10,000 units at $9.78), decreasing direct ownership by 11% to 82,501 units (SEC Form 4)4 - FENNEC PHARMACEUTICALS INC. (0001211583) (Issuer)
- Director Raykov Rosty was granted 5,208 shares, increasing direct ownership by 6% to 92,501 units (SEC Form 4)4 - FENNEC PHARMACEUTICALS INC. (0001211583) (Issuer)
- CHIEF FINANCIAL OFFICER Andrade Robert was granted 2,430 shares, increasing direct ownership by 1% to 170,674 units (SEC Form 4)4 - FENNEC PHARMACEUTICALS INC. (0001211583) (Issuer)
- Director Raykov Rosty exercised 36,207 shares at a strike of $2.45, increasing direct ownership by 71% to 87,293 units (SEC Form 4)4 - FENNEC PHARMACEUTICALS INC. (0001211583) (Issuer)
- Director Raykov Rosty sold $89,200 worth of shares (10,000 units at $8.92), decreasing direct ownership by 16% to 51,086 units (SEC Form 4)4 - FENNEC PHARMACEUTICALS INC. (0001211583) (Issuer)
- CHIEF FINANCIAL OFFICER Andrade Robert was granted 2,431 shares, increasing direct ownership by 1% to 168,244 units (SEC Form 4)4 - FENNEC PHARMACEUTICALS INC. (0001211583) (Issuer)
- Director Raykov Rosty was granted 5,208 shares, increasing direct ownership by 9% to 61,086 units (SEC Form 4)4 - FENNEC PHARMACEUTICALS INC. (0001211583) (Issuer)
- Director Raykov Rosty sold $80,900 worth of shares (10,000 units at $8.09), decreasing direct ownership by 15% to 55,878 units (SEC Form 4)4 - FENNEC PHARMACEUTICALS INC. (0001211583) (Issuer)
- CHIEF FINANCIAL OFFICER Andrade Robert was granted 2,431 shares, increasing direct ownership by 1% to 165,813 units (SEC Form 4)4 - FENNEC PHARMACEUTICALS INC. (0001211583) (Issuer)
- Director Raykov Rosty was granted 5,208 shares, increasing direct ownership by 9% to 65,878 units (SEC Form 4)4 - FENNEC PHARMACEUTICALS INC. (0001211583) (Issuer)
- Director Rallis Chris A exercised 2,127 shares at a strike of $2.35 and sold $9,746 worth of shares (1,119 units at $8.71), increasing direct ownership by 2% to 54,792 units (SEC Form 4)4 - FENNEC PHARMACEUTICALS INC. (0001211583) (Issuer)